Tristel plc (AIM:TSTL)

Market Cap	178.54M +16.1%
Revenue (ttm)	49.54M +13.7%
Net Income	7.86M +28.1%
EPS	0.16 +26.1%
Shares Out	47.93M
PE Ratio	22.94
Forward PE	21.64
Dividend	0.14 (3.81%)
Ex-Dividend Date	Mar 19, 2026

Volume	129,451
Average Volume	194,249
Open	379.00
Previous Close	372.50
Day's Range	365.00 - 380.00
52-Week Range	260.00 - 445.00
Beta	0.22
RSI	33.88
Earnings Date	Mar 2, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 270
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.